The economic impact of severe asthma to low-income families

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 64, Issue 3, 2009, Pages 478-483

  Franco, R ^a,b,e   Nascimento, H F ^c   Cruz, A A ^b,e   Santos, A C ^c,d,e   Souza Machado, C ^b   Ponte, E V ^b   Souza Machado, A ^b   Rodrigues, L C ^d,e   Barreto, M L ^c,e  

^a ProAR   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c Instituto de Saude de Sao Paulo   (Brazil)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Family costs; Quality of life; Severe asthma; Treatment

Indexed keywords

ADULT; ARTICLE; ASTHMA; BRAZIL; COST OF ILLNESS; DISEASE CONTROL; DISEASE SEVERITY; ECONOMIC ASPECT; FAMILY; FEMALE; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HUMAN; INCOME; LOWEST INCOME GROUP; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; WORK RESUMPTION;

ADULT; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRAZIL; BRONCHODILATOR AGENTS; BUDESONIDE; COST OF ILLNESS; ETHANOLAMINES; FAMILY; FEMALE; FENOTEROL; HUMANS; MALE; MIDDLE AGED; POVERTY; QUALITY OF LIFE; RHINITIS;

EID: 60849089651     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2009.01981.x     Document Type: Article

References (25)

1. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee Report. Allergy 2004 59 : 469 478.
2. Toelle B, Peat J, Mellis C, Woolcock J. The costs of childhood asthma to Australian families. Pediatr Pulmonol 1995 19 : 330 335.
3. Cisternas M, Blanc P, Yen H. A comprehensive study of the direct and indirect costs of adult asthma. J Allergy Clin Immunol 2003 6 : 1212 1218.
4. Su TT, Kouyaté B, Flessa S. Catastrophic household expenditure for health care in a low-income society: a study from Nouna District, Burkina Faso. Bull World Health Organ 2006 84 : 21 27.
5. Serra-Batlles J, Plaza V, Morehon E, Comella A, Brugues J. Costs of asthma according to the degree of severity. Eur Respir J 1998 12 : 1322 1326.
6. Neffen H et al. Asthma control in Latin America: the asthma insights and reality in Latin America (AIRLA) survey. Panam J Public Health 2005 17 : 191 197.
7. Rabe K, Adachi M, Lai C. Worldwide severity and control of asthma in children and adults: The global Asthma Insights and Reality surveys. J Allergy Clin Immunol 2004 114 : 40 47.
8. The International Study of Asthma and Allergy in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of asthma symptoms. Eur Respir J 1998 12 : 315 335.
9. Ministry of Health, Brazil. DATASUS. Sistemas de Informações Hospitalares do SUS (SIH/SUS). Available at http://www.datasus.gov.br/catalogo/ sihsus.htm, accessed on February 15th, 2006.
10. Ponte E, Souza-Machado A, Franco R, Souza-Machado C, Cruz AA. Programa de controle da asma e da rinite alérgica na Bahia (ProAR): um modelo de integração entre assistência, ensino e pesquisa. Revista Baiana de Saúde Pública 2004 28 : 124 132.
11. Franco R, Santos A, Nascimento H, Souza-Machado C, Ponte EV, Souza-Machado A et al. Cost-effectiveness analysis of a state funded programme for control of severe asthma. BMC Public Health 2007 7 : 82 87.
12. Global Initiative for asthma (GINA). Global strategy for asthma management and prevention. 2004. Available in http://www.ginasthma.com, accessed on November 15th, 2004.
13. Bousquet J, Cawenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma - ARIA workshop report. J Allergy Clin Immunol 2001 108 : S147 S333.
14. Costa JG, Santos AC, Rodrigues LC, Barreto ML, Roberts JA. Tuberculosis in Salvador, Brazil: costs to health system and families. Revista de Saúde Publica, 2005 39 : 1 6.
15. Juniper EF, Guyatt GH, Epstein RS. Evaluation of impairment of health-related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992 47 : 76 83.
16. Juniper EF, O'Bryne PM, Guyatt GH. Development and validation of the Asthma Control Questionnaire. Am J Respir Crit Care Med 1998 157 : 457 460.
17. Gautrin D, D'Aquino LC, Gagnon G. Comparisson between peak expiratory flow rates (PEFR) and FEV1 in the monitoring of asthmatic subjects at an outpatient clinic. Chest 1994 106 : 1419 1426.
18. Fleiss J. Statistical methods for rates and proportions. ED. New York : Wiley Interscience Publication, 1973.
19. Russel S. The economic burden of illness for households in developing countries: a review of studies focusing malaria, tuberculosis and HIV/AIDS. Am J Trop Med Hyg 2002 71 : 147 155.
20. Wyszewianski L. Families with catastrophic health care expenditures. Health Serv Res 1986 21 : 617 634.
21. Makinen M, Waters H, Rauch M, Almagambetova N, Bitran R, Gilson L. Inequalities in care use and expenditures: empirical data from eight developing countries and countries in transition. Bull World Health Organ 2000 78 : 55 65.
22. Departamento Intersindical de Estatística e estudos Socioeconômicos (DIEESE). PED/RMS-UFBA/SEI/SEPLANTEC/SEADE/DIEESE. Avaliable at http://www.seplam.pms.ba.gov.br/pddua/anexos/anexo08.htm-123k, accessed on March 3rd, 2006.
23. Mclntyre D, Theide M. A Review of Studies Dealing with Economic and Social Consequences of High Medical Expenditure with a Special Focus on the Medical Poverty Trap: Cape Town, South Africa. Cape Town : Health Economics Unit, Universisty of Cape Town, 2003.
24. Bachmann M, Booysen F. Health and economic impact of HIV/AIDS on South African households: a cohort study. BMC Public Health, 2003 3 : 1 8.
25. Sackett DL. Bias in analytic research. J Chronic Dis 1979 32 : 51 63.